Cyclerion Therapeutics, Inc.
CYCN
$3.13
-$0.05-1.57%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
5/4/2026
-
PR Newswire
4/20/2026
-
Yahoo! Finance: News
4/20/2026
-
Insider Monkey
4/9/2026
-
PR Newswire
4/8/2026
-
PR Newswire
4/7/2026
-
Globe Newswire
4/7/2026
-
Globe Newswire
4/3/2026
-
Globe Newswire
4/2/2026
-
PR Newswire
4/2/2026
-
Business Wire
4/2/2026
-
Benzinga
4/2/2026
-
Benzinga
4/2/2026
-
Ticker Report
4/1/2026
-
PR Newswire
4/1/2026
-
TipRanks Financial Blog
4/1/2026
-
MarketBeat
4/1/2026
-
MarketBeat
4/1/2026
-
Benzinga
4/1/2026
-
SeekingAlpha
4/1/2026
-
Seeking Alpha: Transcripts
4/1/2026
-
The Fly
4/1/2026
-
Business Wire
3/18/2026
-
Ticker Report
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
--
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
--
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Tuesday, March 31, 2026
Period Date
Wednesday, December 31, 2025
Next Filing
Week of May 4 and 8 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
857 327 8778
Address
245 First Street, Riverview II
Cambridge, MA 02142
Cambridge, MA 02142
Country
Year Founded
Business Description
Sector
Cyclerion Therapeutics, Inc., a biopharmaceutical company, engages in the development of treatments for serious diseases serious diseases with novel sGC stimulators in both the central nervous...
more